Results 21 to 30 of about 3,970 (174)
Hemodynamic Instability during Thyroidectomy in Graves’ Disease
Journal of Investigative Surgery, 2022 Background The aim of this study was to investigate the changes in vital signs and hemodynamic status that occur in patients during the intraoperative course of thyroidectomy in Graves’ Disease (GD).
Sami Acar +6 more
doaj +1 more source
Model predictive control for the prescription of antithyroid agents
CoRR, 2023 2 ...
Maylin Menzel +3 more
openaire +2 more sources
Prediction for recurrence following antithyroid drug therapy for Graves’ hyperthyroidism [PDF]
Archives of Endocrinology and Metabolism, 2023 Objective: A common problem with antithyroid drugs (ATD) treatment in patients with Graves’ disease (GD) is the high recurrence rate after drug withdrawal. Identifying risk factors for recurrence is crucial in clinical practice.
Huan Weng +3 more
doaj +1 more source
Pediatric Graves’ disease: insights into clinical characteristics and treatment outcomes [PDF]
Archives of Endocrinology and MetabolismObjective: To identify early manifestations of Graves’ disease in young patients and its treatment outcomes. Subjects and methods: This was a hospital-based review of case records of 47 children (aged 1 month to 18 years) with Graves’ disease from 2011 ...
Akshatha Anand +2 more
doaj +1 more source
Journal of the ASEAN Federation of Endocrine Societies, 2019 A 34-year-old Filipino with Graves’ disease on methimazole came in due to fever, sore throat and jaundice. Patient was initially diagnosed with methimazole induced agranulocytosis and drug induced liver injury.
Natalia Wijaya, Celeste Ong-Ramos
doaj +1 more source
Predicting remission of Graves' disease following treatment with antithyroid drugs
Клинический разбор в общей медицине, 2023 Graves' disease (GD) is among the most prevalent organ-specific diseases and is one of the most common causes of hyperthyroidism in regions with normal iodine supply.
Natalya V. Drogashevskaya +5 more
doaj +1 more source
Peri-operative concerns in a patient with thyroid storm secondary to molar pregnancy
Indian Journal of Anaesthesia, 2015 Awareness of the presence of thyroid function abnormalities in patients with molar pregnancy is important for its prompt diagnosis and management. We report the development of thyroid storm in the immediate post-operative period in a 25-year-old female ...
Tanvir Samra +3 more
doaj +1 more source
Mechanism of the Inhibition of Enzymatic Halogenation by Antithyroid Agents
Journal of Biological Chemistry, 1966 Abstract Antithyroid agents of the thiourea type (thiourea, thiouracil, and 5-vinyl-2-oxazolidinethione) inhibit the enzymatic halogenation reactions catalyzed by chloroperoxidase. These compounds are competitive with the halogen acceptor molecule and serve as substrates for chloroperoxidase. These antithyroid agents are oxidized by chloroperoxidase in
D R, Morris, L P, Hager
openaire +2 more sources
Long-Term Antithyroid Drug Therapy in Smoldering or Fluctuating-Type Graves’ Hyperthyroidism with Potassium Iodide [PDF]
Endocrinology and MetabolismGraves’ hyperthyroidism is characterized by stimulation of the thyroid gland by thyroid-stimulating hormone receptor antibodies (TRAbs). Antithyroid drug (ATD) continuation is recommended as long as the thyroid gland is stimulated. Goiter size, thyroidal
Ken Okamura
doaj +1 more source
A Crystalline and Thermally Stable Selenocysteine Selenenic Acid
Angewandte Chemie International Edition, EarlyView.The long‐sought catalytic intermediate of selenoproteins, selenocysteine selenenic acid (Sec–SeOH), is isolated for the first time at ambient temperature. A bioinspired selenopeptide sequence encapsulated within a protective molecular cradle and an oxidant‐free route from selenenyl iodide (Sec–SeI) enable the isolation of Sec–SeOH. Contrary to the long‐
Ryosuke Masuda, Satoru Kuwano, Kei Goto
wiley +1 more source